Navigation Links
Peer-Reviewed Study Published on Active Noise Control Device in Simulated NICU
Date:7/18/2020

A study has been published in the journal PLOS ONE that demonstrates the effectiveness of the Invictus Medical Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal intensive care unit (NICU) environment. The study reported that the Neoasis™ device attenuated the alarm sounds from patient monitors, ventilators and other bedside devices that would affect the infants cared for in incubators.

“The problems associated with the effect of NICU noise on the incubated preemie patient are documented in the literature in terms of sleep and weight gain, and effective solutions remain elusive.” said George Hutchinson, Invictus Medical’s Chief Executive Officer. “We are optimistic that this bench-top study foretells a great means of protecting these vulnerable patients.”

The greatest attenuation achieved was 14.4 decibels for a typical patient monitor alarm, equating to a 5.5-fold decrease in sound pressure level that the incubator-oriented patient would experience. The study was conducted in the simulation center of the Children’s Hospital of San Antonio, supported by the simulation center’s staff. The results of the study are available at https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0235287.

The Neoasis™ is still in development and is not currently being distributed.

About Invictus Medical
Invictus Medical is a San Antonio, Texas-based medical device company that aims to ensure that children are able to attain their developmental milestones. As evidenced by their record of National Science Foundation and National Institutes of Health grants, Invictus Medical has been at the forefront of pediatric care since its founding in 2012. Invictus Medical is a privately held company. For more information about Invictus Medical, please see http://www.invictusmed.com.

Read the full story at https://www.prweb.com/releases/peer_reviewed_study_published_on_active_noise_control_device_in_simulated_nicu/prweb17255755.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology news :

1. 3-D Printing and Additive Manufacturing: Preview issue of groundbreaking peer-reviewed journal now available
2. Peer-reviewed paper says all ivory markets must close
3. Peer-Reviewed Paper in Frontiers in Bioengineering and Biotechnology Reveals that uBiome Has the Largest Patent Portfolio in the Microbiome Space
4. Rescue me: New study finds animals do recover from neglect
5. Study led by NUS scientists reveals escalating cost of forest conservation
6. BUSM study reveals novel mechanism by which UVA contributes to photoaging of skin
7. Monoclonal Antibody with Xencors High ADCC Fc Technology Enters Phase 2 Study in B-cell Acute Lymphoblastic Leukemia
8. University of Houston engineering professor awarded grant to study melanoma treatment
9. Study examines effects of genetic variants for infants with neonatal abstinence syndrome
10. Zebrafish study suggests that vitamin B2 (riboflavin) is an antidote to cyanide poisoning
11. Study finds possible alternative to bariatric weight loss surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/7/2020)... ... August 06, 2020 , ... Nine middle school teachers ... Scholar Program, a unique professional development program that provides advanced STEM (science, technology, ... science teachers nationwide. , Created in partnership between the National Stem Cell Foundation ...
(Date:8/3/2020)... , ... August 03, 2020 , ... ... announced a new partnership with medical equipment manufacturer, Spectrum Solutions, to provide COVID-19 ... to strengthen their laboratory supply chain for more than 10 years. Early in ...
(Date:7/31/2020)... ... July 30, 2020 , ... Justin Zamirowski ... with a near term focus on Type 2 diabetes and associated comorbidities. , ... multiple therapeutic areas and classes. As Chief Commercial Officer, Justin will lead ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... ... August 11, 2020 , ... ... cold chain validation engineering firm, is making available for free its new ... to incorporate concurrent transport simulation testing into today’s biologics licensing application (BLA). ...
(Date:8/3/2020)... ... August 03, 2020 , ... ... announced Jim Corrigan, President and CEO has been named one of the 100 ... of industry sectors, PharmaVoice 100 honorees are selected based on how they have ...
(Date:7/31/2020)... ... 29, 2020 , ... G-CON Manufacturing, the leader in off-site ... FOR LIFE.” The adoption of this taglines comes at a time of tremendous ... to provide patients with urgently needed vaccines and other lifesaving pharmaceutical treatments. G-CON’s ...
(Date:7/31/2020)... ... July 29, 2020 , ... Editas ... global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, ... entered into a strategic partnership whereby Catalent will provide support for the development, ...
Breaking Biology Technology: